Anderberg, Joseph,Gray, Jeff,McPherson, Paul,Nakamura, Kevin
申请号：
AU2015200266
公开号：
AU2015200266A1
申请日:
2015.01.21
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015200266A120150212.pdf#####ABSTRACT The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Clusterin, Hearttype fatty acid binding protein, Hepatocyte growth factor, Interferon gamma, Interleukin- 12 subunit beta, Interleukin-16, Interleukin-2, 72 kDa type IV collagenase, Matrix metalloproteinase-9, Midkine, and Serum amyloid P-component as diagnostic and prognostic biomarkers in renal injuries.
